Study of Bendamustine, Gemcitabine and Vinorelbine Regimen in Relapsed/Refractory Classical Hodgkin Lymphoma

NCT07450508 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Classical Hodgkin Lymphoma Relapsed

Interventions

COMBINATION_PRODUCT: BEGEV (Bendamustine, Gemcitabine,Vinorelbine)
COMBINATION_PRODUCT: GDP(Gemcitabine, Dexamethasone and Cisplatin)

Sponsor

Cairo University